AleraCare Appoints Joseph Cosgrove as CEO and Board Member Amid Pivotal Merger with PURE Healthcare
AleraCare, a nationally recognized provider of infusion and specialty pharmacy services, has officially announced the appointment of Joseph Cosgrove as its new Chief Executive Officer and member of the Board of Directors. This decision was unanimously approved by AleraCare’s Board of Directors and comes as the company undergoes a significant leadership transition. The announcement also confirms that Russ Corvese, the co-founder and outgoing CEO of AleraCare, will retire from his role effective October 13, 2025, though he will continue to provide guidance and support as an advisor during the leadership transition period.
The appointment of Mr. Cosgrove marks a key milestone for AleraCare at a time of notable strategic growth. The company is in the process of merging with PURE Healthcare under a definitive agreement designed to create a leading national platform for integrated, patient-focused infusion and specialty care services. This merger is anticipated to close in the fourth quarter of 2025 and is subject to customary closing conditions. By combining the capabilities, reach, and expertise of both organizations, AleraCare and PURE Healthcare aim to strengthen their ability to deliver comprehensive, high-quality care to patients across the United States.
Russ Corvese’s Legacy and Contributions
Russ Corvese, who co-founded AleraCare, has played an essential role in shaping the company into one of the country’s most respected providers of outpatient and home-based care solutions. Under his leadership, the company expanded its footprint nationally, developed and enhanced clinical programs, and solidified a reputation for compassionate, patient-centered care. His tenure as CEO was defined by strategic growth, operational excellence, and the creation of scalable healthcare models that prioritize both clinical quality and patient convenience.
“Leading AleraCare has been one of the greatest privileges of my career,” said Mr. Corvese. “I am extremely proud of what we have accomplished together in supporting patients and their families. As I step back, I am confident that Joe’s experience, leadership, and vision — especially as the company prepares to merge with PURE Healthcare — will guide AleraCare into a new era of growth and innovation.”
Board Perspective on Leadership Transition
Stephen Hallenbeck, Partner at Hildred Capital and member of AleraCare’s Board of Directors, emphasized the board’s support for the leadership transition and expressed gratitude for Mr. Corvese’s long-standing contributions. “We thank Russ for his visionary leadership and tireless dedication to the patients we serve,” said Hallenbeck. “At the same time, we are thrilled to welcome Joe as our Chief Executive Officer and to our Board of Directors. We firmly believe that his extensive leadership experience and operational expertise, combined with the pending merger with PURE Healthcare, will position the company for its next phase of growth and continued success.”
Joseph Cosgrove: Proven Healthcare Leader
Joseph Cosgrove brings over 25 years of executive leadership experience across healthcare services, life sciences, and private equity–backed growth companies. His career has been characterized by successfully building innovative healthcare platforms, expanding access to patient-centered care, and driving operational and financial excellence.
Before joining AleraCare, Mr. Cosgrove served as Chairman, President, and CEO of two private equity–backed healthcare services companies, Pentec Health and Leiters Health. During his tenure at both organizations, he spearheaded major growth initiatives, oversaw multiple acquisitions, and forged strategic partnerships with leading health systems and payers. His leadership was instrumental in advancing care models that balance clinical quality with patient convenience, placing both companies at the forefront of healthcare transformation.
In addition to his executive experience, Mr. Cosgrove has contributed his expertise to numerous boards and industry advisory groups, providing strategic guidance on areas including value-based care, home and community-based services, and the integration of technology into patient care delivery. His professional accomplishments reflect a commitment to improving healthcare access and outcomes while maintaining operational efficiency and sustainable growth.
Vision for AleraCare and the PURE Healthcare Merger
Upon his appointment, Mr. Cosgrove expressed enthusiasm for his new role and highlighted the significant opportunity represented by AleraCare’s merger with PURE Healthcare. “I am honored to succeed Russ and build on the strong foundation that he and the team have established,” said Mr. Cosgrove. “AleraCare’s mission to deliver outstanding care and support to patients and their families is one I am deeply committed to. The pending merger with PURE Healthcare represents a tremendous opportunity to expand our reach and impact, and I look forward to collaborating with our talented team and Board to bring that vision to life.”
The merger is expected to create a national platform that combines the strengths of two leading healthcare providers. The integration of AleraCare and PURE Healthcare will allow for greater operational efficiencies, expanded patient access, and enhanced clinical programs. Together, the companies aim to set a new standard in the delivery of infusion and specialty care services, emphasizing patient-centered solutions that prioritize safety, convenience, and high-quality outcomes.
AleraCare’s Strategic Growth and National Impact
AleraCare’s expansion strategy has consistently focused on delivering high-quality, home-based, and outpatient care across the United States. The company’s portfolio of services includes infusion therapy, specialty pharmacy, and a range of supportive care programs designed to improve patient adherence, outcomes, and satisfaction. Through its network of highly trained clinicians and robust care delivery infrastructure, AleraCare has become a trusted partner for health systems, payers, and patients alike.
Mr. Cosgrove’s appointment is expected to accelerate AleraCare’s strategic initiatives, particularly as the company prepares for its integration with PURE Healthcare. His leadership experience in navigating complex growth strategies and operational transformations positions him to lead the organization through this critical phase, ensuring that the merger enhances service quality, operational efficiency, and patient experience.
Commitment to Patients and the Healthcare Community
Throughout its history, AleraCare has remained committed to delivering compassionate, patient-centered care that meets the needs of diverse populations. This commitment has guided the company’s clinical programs, technology adoption, and operational practices. With the leadership transition and the pending merger, AleraCare aims to extend this commitment even further, providing patients with access to advanced therapies and integrated care models that improve outcomes while minimizing complexity.
“As we look toward the future, our focus remains on empowering patients and their families through exceptional care,” said Mr. Cosgrove. “By combining our resources and expertise with PURE Healthcare, we will be able to expand access to life-changing therapies and enhance the overall patient experience. This is an exciting time for AleraCare, and I am proud to lead the organization through this transformative period.”
